uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary report.
Show others and affiliations
2010 (English)In: Clinical Therapeutics, ISSN 0149-2918, E-ISSN 1879-114X, Vol. 32, no 10, 1704-1712 p.Article in journal (Refereed) Published
Abstract [en]

The current regulatory approaches and criteria for bioequivalence evaluation were considered adequate for the assessment of therapeutic equivalence and interchangeability of conventional monophasic MR products. Additional measures may occasionally be needed to establish the bioequivalence of multiphasic MR products, and development of such measures is an important objective. The metric of partial AUC was proposed for products designed to have a rapid drug action followed by sustained response.

Place, publisher, year, edition, pages
2010. Vol. 32, no 10, 1704-1712 p.
National Category
Pharmaceutical Sciences
URN: urn:nbn:se:uu:diva-151831DOI: 10.1016/j.clinthera.2010.09.014PubMedID: 21194592OAI: oai:DiVA.org:uu-151831DiVA: diva2:411419
Available from: 2011-04-18 Created: 2011-04-18 Last updated: 2011-04-21Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Department of Pharmacy
In the same journal
Clinical Therapeutics
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 186 hits
ReferencesLink to record
Permanent link

Direct link